Molecular pathology and pathobiology of osteoarthritic cartilage

被引:250
作者
Aigner, T [1 ]
McKenna, L [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany
关键词
cartilage; osteoarthritis; collagen; proteoglycan; apoptosis; mRNA expression; cDNA array;
D O I
10.1007/s00018-002-8400-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biochemical properties of articular cartilage rely on the biochemical composition and integrity of its extracellular matrix. This matrix consists mainly of a collagen network and the proteoglycan-rich ground substance. In osteoarthritis, ongoing cartilage matrix destruction takes place, leading to a progressive loss in joint function. Beside the degradation of molecular matrix components, destabilization of supramolecular structures such as the collagen network and changes in the expression profile of matrix molecules also take place. These processes, as well as the pattern of cellular reaction, explain the pathology of osteoarthritic cartilage degeneration. The loss of histochemical proteoglycan staining reflects the damage at the molecular level, whereas the supramolecular matrix destruction leads to fissuring and finally to the loss of the cartilage. Chondrocytes react by increasing matrix synthesis, proliferating, and changing their cellular phenotype. Gene expression mapping in situ and gene expression profiling allows characterization of the osteoarthritic cellular phenotype, a key determinant for understanding and manipulating the osteoarthritic disease process.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 143 条
[1]  
Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO
[2]  
2-A
[3]   ACTIVATION OF COLLAGEN TYPE-II EXPRESSION IN OSTEOARTHRITIC AND RHEUMATOID CARTILAGE [J].
AIGNER, T ;
STOSS, H ;
WESELOH, G ;
ZEILER, G ;
VONDERMARK, K .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1992, 62 (06) :337-345
[4]   Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: A hypothesis [J].
Aigner, T ;
Dudhia, J .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) :287-291
[5]   Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage [J].
Aigner, T ;
Vornehm, SI ;
Zeiler, G ;
Dudhia, J ;
vonderMark, K ;
Bayliss, MT .
ARTHRITIS AND RHEUMATISM, 1997, 40 (03) :562-569
[6]   INDEPENDENT EXPRESSION OF FIBRIL-FORMING COLLAGEN-I, COLLAGEN-II, AND COLLAGEN-III IN CHONDROCYTES OF HUMAN OSTEOARTHRITIC CARTILAGE [J].
AIGNER, T ;
BERTLING, W ;
STOSS, H ;
WESELOH, G ;
VONDERMARK, K .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :829-837
[7]  
AIGNER T, 1995, LAB INVEST, V73, P236
[8]  
Aigner T, 1997, AM J PATHOL, V150, P2133
[9]   Generation and characterization of aggrecanase - A soluble, cartilage-derived aggrecan-degrading activity [J].
Arner, EC ;
Pratta, MA ;
Trzaskos, JM ;
Decicco, CP ;
Tortorella, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6594-6601
[10]   Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro [J].
Atkinson, JC ;
Ruhl, M ;
Becker, J ;
Ackermann, R ;
Schuppan, D .
EXPERIMENTAL CELL RESEARCH, 1996, 228 (02) :283-291